Bionano Genomics, Inc. (BMV:BNGO)

Bionano Genomics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	311	613	1,241	8,456	17,726	9,388
Market Cap Growth	-32.77%	-50.61%	-85.32%	-52.30%	88.81%	1415.38%
Enterprise Value	231	832	338	5,144	11,041	9,332
Last Close Price	31.00	372.00	2034.60	16800.00	37080.00	-
PS Ratio	0.59	0.96	2.03	15.59	48.09	55.49
PB Ratio	0.34	0.83	0.76	1.74	2.57	13.45
P/TBV Ratio	0.38	1.15	1.18	3.31	3.40	17.85
EV/Sales Ratio	0.44	1.30	0.55	9.49	29.95	55.15
Debt / Equity Ratio	0.35	0.77	0.83	0.05	0.03	0.47
Asset Turnover	0.35	0.21	0.14	0.08	0.08	0.19
Inventory Turnover	1.45	1.79	1.01	1.04	1.80	1.70
Quick Ratio	1.14	0.38	0.76	3.36	11.70	4.61
Current Ratio	2.12	1.06	1.40	4.38	12.47	5.23
Return on Equity (ROE)	-78.22%	-170.33%	-134.56%	-45.21%	-38.92%	-212.46%
Return on Assets (ROA)	-19.31%	-32.76%	-33.22%	-23.66%	-21.58%	-51.09%
Return on Capital (ROIC)	-23.24%	-40.02%	-39.70%	-26.60%	-23.65%	-61.67%
Return on Capital Employed (ROCE)	-45.90%	-194.00%	-121.30%	-47.70%	-21.30%	-71.90%
Earnings Yield	-227.55%	-380.82%	-316.71%	-30.59%	-8.38%	-8.71%
FCF Yield	-	-234.66%	-172.83%	-29.53%	-8.49%	-8.12%
Buyback Yield / Dilution	-220.18%	-123.37%	-18.05%	-4.49%	-165.50%	-596.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.